Charles H Mitch Selected Research

LY 243670

8/2008

Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles H Mitch Research Topics

Disease

2	Obesity 08/2008 - 06/2003
2	Body Weight (Weight, Body) 08/2008 - 06/2003
1	Major Depressive Disorder (Major Depressive Disorders) 12/2016
1	Miosis 10/2014
1	Mydriasis 10/2014
1	Neoplasms (Cancer) 01/2013
1	Heart Diseases (Heart Disease) 01/2013
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2013
1	Pain (Aches) 11/2011

Drug/Important Bio-Agent (IBA)

2	Opioid Receptors (Opioid Receptor)IBA 11/2011 - 06/2003
1	Glutamic Acid (Glutamate)FDA Link 12/2016
1	Antidepressive Agents (Antidepressants)IBA 12/2016
1	AticaprantIBA 10/2014
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2014
1	Morphine (MS Contin)FDA LinkGeneric 10/2014
1	Naloxone (Narcan)FDA LinkGeneric 10/2014
1	Naltrexone (ReVia)FDA LinkGeneric 10/2014
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2014
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2014
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2013
1	Histone Deacetylase InhibitorsIBA 01/2013
1	Vorinostat FDA Link 01/2013
1	Biological ProductsIBA 11/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2011
1	LY 243670IBA 08/2008

Therapy/Procedure

1	Therapeutics 01/2013